Ad is loading...
MCRXF
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Nov 7 closing price
RBOT
Price
$9.36
Change
-$1.16 (-11.03%)
Updated
Nov 15 closing price
Ad is loading...

MCRXF vs RBOT

Header iconMCRXF vs RBOT Comparison
Open Charts MCRXF vs RBOTBanner chart's image
MICRO X
Price$0.04
Change-$0.00 (-0.00%)
Volume$5K
CapitalizationN/A
Vicarious Surgical
Price$9.36
Change-$1.16 (-11.03%)
Volume$27.98K
CapitalizationN/A
MCRXF vs RBOT Comparison Chart
Loading...
RBOT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
MCRXF vs. RBOT commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCRXF is a Hold and RBOT is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (MCRXF: $0.04 vs. RBOT: $9.36)
Brand notoriety: MCRXF and RBOT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MCRXF: 104% vs. RBOT: 136%
Market capitalization -- MCRXF: $39.55M vs. RBOT: $51.42M
MCRXF [@Medical Specialties] is valued at $39.55M. RBOT’s [@Medical Specialties] market capitalization is $51.42M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCRXF’s FA Score shows that 0 FA rating(s) are green whileRBOT’s FA Score has 1 green FA rating(s).

  • MCRXF’s FA Score: 0 green, 5 red.
  • RBOT’s FA Score: 1 green, 4 red.
According to our system of comparison, RBOT is a better buy in the long-term than MCRXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RBOT’s TA Score shows that 5 TA indicator(s) are bullish.

  • RBOT’s TA Score: 5 bullish, 4 bearish.

Price Growth

MCRXF (@Medical Specialties) experienced а 0.00% price change this week, while RBOT (@Medical Specialties) price change was +11.43% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

RBOT is expected to report earnings on Aug 05, 2024.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RBOT($51.4M) has a higher market cap than MCRXF($39.6M). RBOT YTD gains are higher at: -14.917 vs. MCRXF (-53.488). MCRXF has higher annual earnings (EBITDA): -10.33M vs. RBOT (-69.19M). RBOT has more cash in the bank: 98.2M vs. MCRXF (18.3M). MCRXF has less debt than RBOT: MCRXF (12.6M) vs RBOT (14.8M). MCRXF has higher revenues than RBOT: MCRXF (15.6M) vs RBOT (0).
MCRXFRBOTMCRXF / RBOT
Capitalization39.6M51.4M77%
EBITDA-10.33M-69.19M15%
Gain YTD-53.488-14.917359%
P/E RatioN/A51.55-
Revenue15.6M0-
Total Cash18.3M98.2M19%
Total Debt12.6M14.8M85%
TECHNICAL ANALYSIS
Technical Analysis
RBOT
RSI
ODDS (%)
Bearish Trend 4 days ago
65%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
78%
Momentum
ODDS (%)
Bullish Trend 4 days ago
62%
MACD
ODDS (%)
Bullish Trend 4 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
61%
Advances
ODDS (%)
Bullish Trend 8 days ago
71%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
69%
Aroon
ODDS (%)
Bullish Trend 4 days ago
49%
View a ticker or compare two or three
Ad is loading...
RBOT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IBD23.700.04
+0.17%
Inspire Corporate Bond ETF
BTR27.03-0.39
-1.42%
Beacon Tactical Risk ETF
IZRL20.43-0.49
-2.32%
ARK Israel Innovative Technology ETF
ONT.X0.214950-0.016861
-7.27%
Ontology cryptocurrency
XTZ.X0.792759-0.080116
-9.18%
Tezos cryptocurrency

MCRXF and

Correlation & Price change

A.I.dvisor tells us that MCRXF and VTAK have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MCRXF and VTAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCRXF
1D Price
Change %
MCRXF100%
N/A
VTAK - MCRXF
21%
Poorly correlated
-6.00%
MXCT - MCRXF
11%
Poorly correlated
-0.58%
LDXHF - MCRXF
2%
Poorly correlated
N/A
ISPC - MCRXF
1%
Poorly correlated
-3.45%
RBOT - MCRXF
0%
Poorly correlated
-11.03%
More

RBOT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RBOT has been loosely correlated with NXL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if RBOT jumps, then NXL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RBOT
1D Price
Change %
RBOT100%
-11.03%
NXL - RBOT
39%
Loosely correlated
+2.93%
ELUT - RBOT
31%
Poorly correlated
-7.05%
RVTY - RBOT
31%
Poorly correlated
-5.63%
TMO - RBOT
30%
Poorly correlated
-3.74%
IDXX - RBOT
30%
Poorly correlated
-0.65%
More